Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118522) titled 'Analysis of ANGPT4 Expression and Clinical Relevance in Pan-Cancer' on Feb. 6.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
Renal cell carcinoma, renal clear cell carcinoma
Intervention:
Tumour Tissue Group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-06
Target Sample Size: Tumour Tissue Group:30; Paired normal tissue sections adjacent to the tumour:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=309622
Disclaimer: ...